Skip to main content
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.3500
-0.0020 (-0.57%)
Apr 17, 2025, 4:00 PM EDT

Northwest Biotherapeutics Revenue

In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%. Northwest Biotherapeutics had revenue of $231.00K in the quarter ending December 31, 2024, a decrease of -48.09%.

Revenue
1.38M
Revenue Growth
-28.47%
P/S Ratio
354.23
Revenue / Employee
55.28K
Employees
25
Market Cap
489.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.38M-550.00K-28.47%
Dec 31, 20231.93M249.00K14.80%
Dec 31, 20221.68M678.00K67.46%
Dec 31, 20211.01M-286.00K-22.15%
Dec 31, 20201.29M-1.12M-46.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 210.49M
American Oncology Network 1.76B
Longduoduo Company 6.01M
Revenue Rankings

Northwest Biotherapeutics News

More News